Xiaopei Hao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Zhengzhou University, Henan Cancer Hospital, Nanjing Medical University · ORCID：0000-0002-5972-392X

发表论文 39 篇 · 总被引 988 次 · h-index 11

代表论文

• Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing (2022 · Redox Biology · 被引 308)
• MGP promotes CD8 + T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer (2022 · International Journal of Biological Sciences · 被引 119)
• CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ (2022 · Journal of Experimental & Clinical Cancer Research · 被引 104)
• Inhibition of APOE potentiates immune checkpoint therapy for cancer (2022 · International Journal of Biological Sciences · 被引 40)
• CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma (2024 · Cancer Letters · 被引 36)
• eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma (2025 · Journal of Hepatology · 被引 28)